SciClone Pharmaceuticals (SCLN)
Add to Watchlists Create an Alert
4.86
-0.11 -2.21%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
SciClone Pharmaceuticals Revenue Quarterly YoY Growth:
-16.47% for Dec. 31, 2012SciClone Pharmaceuticals Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -16.47% |
| Sept. 30, 2012 | 3.54% |
| June 30, 2012 | 29.58% |
| March 31, 2012 | 89.59% |
| Dec. 31, 2011 | 68.00% |
| Sept. 30, 2011 | 72.08% |
| June 30, 2011 | 54.28% |
| March 31, 2011 | 20.60% |
| Dec. 31, 2010 | 30.25% |
| Sept. 30, 2010 | 32.48% |
| June 30, 2010 | -5.81% |
| March 31, 2010 | 19.20% |
| Dec. 31, 2009 | 18.37% |
| Sept. 30, 2009 | 20.32% |
| June 30, 2009 | 58.82% |
| March 31, 2009 | 41.71% |
| Dec. 31, 2008 | 52.89% |
| Sept. 30, 2008 | 51.76% |
| June 30, 2008 | 54.48% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
SCLN Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Lannett Company | 27.16% |
| DepoMed | 119.2% |
| POZEN | -98.15% |
SCLN Revenue Quarterly YoY Growth Rankings
| Overall |
46th percentile 4295 of 8011 |
| Sector |
37th percentile 427 of 687 in Healthcare |
| Industry |
40th percentile 41 of 69 in Drug Manufacturers - Specialty & Generic |
SCLN Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -16.47% | Dec 2012 |
| Maximum | 89.59% | Mar 2012 |
| Average | 36.61% |
